Company intelligence / Profile preview

Adecto Pharmaceuticals

Boston, Massachusetts, United Statesadectopharma.com ↗
Ownership
Private
Employees
~8
Development stage
Other
01

Overview

Adecto Pharmaceuticals has developed proprietary monoclonal antibodies targeting the ADAM8 protein for the treatment of aggressive cancers. Proof-of-concept studies in mice have shown that inhibiting ADAM8 slows tumor growth and metastasis. The company’s lead programs are in preclinical development with plans to move into clinical trials targeting breast cancer—including triple-negative subtypes—where no effective targeted therapies currently exist. A companion diagnostic to identify eligible patients is also under development.

No clinical results are available yet as all programs remain preclinical.

The company was co-founded by Dr. Gail Sonenshein and Dr. Nora Mineva from Tufts University.

Therapeutic areas
Oncology
Modalities
Monoclonal antibodies
Industry
Biotech
02

Partnerships

NIH SEED Office support/grantsNational Institutes of Health grants

Beyond the preview

Go deeper on Adecto Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adecto Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call